Company intelligence / Profile preview

Omega Diagnostics Group

Alva, Scotland

Ownership: Private
Employees: ~171
Development stage: Other

Overview

Omega Diagnostics Group is focused on developing and distributing medical diagnostic products in the IVD market, with a strong presence in allergy, health & wellbeing, and global health. The company has a global reach, with products used in over 75 countries. Recent developments include the disposal of its infectious disease business to Novacyt SA, except for VISITECT CD4.

Therapeutic areas: GastroenterologyImmunologyInfectious Diseases
Modalities: In Vitro Diagnostics (IVD)Tests for infectious diseasesTests for food sensitivity and gut healthTests for allergy and specific immunotherapy
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Omega Diagnostics Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omega Diagnostics Group.

Explore the full profile